Bio-Techne (TECH) Long-Term Debt Repayments (2014 - 2018)
Bio-Techne's quarterly Long-Term Debt Repayments came in at $357.1 million in Q3 2018, up 5852.08% year-on-year from $6.0 million in Q3 2017, and up 5852.08% quarter-over-quarter from $6.0 million in Q3 2017.
Bio-Techne has reported Long-Term Debt Repayments for 4 years, with the latest figure at $357.1 million in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 357.13 Mn |
| Sep 30, 2018 | 357.13 Mn |
| Sep 30, 2017 | 6.00 Mn |
| Sep 30, 2017 | 6.00 Mn |
| Mar 31, 2015 | 1.95 Mn |
| Mar 31, 2015 | 1.95 Mn |
| Dec 31, 2014 | 6.00 Mn |
| Dec 31, 2014 | 6.00 Mn |
| Sep 30, 2014 | 13.00 Mn |
| Sep 30, 2014 | 13.00 Mn |